12:00 AM
 | 
Dec 24, 2012
 |  BC Week In Review  |  Company News  |  Deals

PRA International, WuXi PharmaTech deal

CROs WuXi and PRA said they will form a 51/49 JV to provide clinical research services to the Chinese market. The JV, which will be an...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >